A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process
Frontiers in Computational Neuroscience · 04.06.2025 · 19
DOI: 10.3389/fncom.2025.1564932 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Computational Neuroscience, online erschienen am 04.06.2025. Verfasst von Shuwu Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Background
In response to the shortcomings of the current Alzheimer’s disease (AD) early populations assessment, which is based on neuropsychological scales with high subjectivity, low accuracy of repeated measurements, tedious process and dependence on physicians, it was found that digital biomarkers based on the writing process can effectively characterize the cognitive deficits of patients with mild cognitive impairment (MCI) due to AD.
Methods
This study designed a digital writing assessment paradigm, extracted dynamic handwriting and image data during the paradigm assessment process, and analyzed digital biomarkers of the writing process to assess subjects’ cognitive functions. A total of 72 subjects, including 34 health controls (HC) and 38 MCI due to AD, were enrolled in this study.
Results
Their combined screening efficacy of digital biomarkers based on the MCI writing process due to AD populations having an area under curve (AUC) of 0.918, and a confidence interval (CI) of 0.854–0.982, was higher than the Montreal Cognitive Assessment Scale (AUC = 0.859, CI = 0.772–0.947) and the Mini-mental State Examination Scale (AUC = 0.783, CI = 0.678–0.888).
Conclusion
Therefore, digital biomarkers based on the writing process can characterize and quantify the cognitive function of MCI due to AD populations at a fine-grained level, which is expected to be a new method for intelligent screening and early warning of early AD populations in a community-based physician-free setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou, China.
- School of Information Engineering, Hangzhou Medical College, Hangzhou, China.
- Zhejiang Engineering Research Center for Brain Cognition and Brain Diseases Digital Medical Instruments, Hangzhou Medical College, Hangzhou, China.
- Department of Neurology, Second Medical Center of Chinese PLA General Hospital, Beijing, China.
Zitieren
APA
Li, S., Li, K., Liu, J., Huang, S., Wang, C., Tu, Y., Wang, B., Zhang, P., Luo, Y., Zhang, Y., & Chen, T. (2025). A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process. Frontiers in Computational Neuroscience, 19. https://doi.org/10.3389/fncom.2025.1564932
Vancouver
Li S, Li K, Liu J, Huang S, Wang C, Tu Y, et al. A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process. Frontiers in Computational Neuroscience. 2025;19. doi:10.3389/fncom.2025.1564932
BibTeX
@article{Li2025,
author = {Li, Shuwu and Li, Kai and Liu, Jiakang and Huang, Shouqiang and Wang, Chen and Tu, Yuting and Wang, Bo and Zhang, Pengpeng and Luo, Yuntian and Zhang, Yanli and Chen, Tong},
title = {A new method for community-based intelligent screening of early Alzheimer’s disease populations based on digital biomarkers of the writing process},
journal = {Frontiers in Computational Neuroscience},
year = {2025},
volume = {19},
doi = {10.3389/fncom.2025.1564932}
}
EUVIMED